Bacterial survival, lymph node pathology, and serological responses of bison (Bison bison) vaccinated with Brucella abortus strain RB51 or strain 19.
From August 1993 to June 1994, 3 month-old bison (Bison bison) were vaccinated with Brucella abortus strain RB51 (SRB51, n = 6), strain 19 (S19, n = 3), or with saline (n = 1) and serologic responses and persistence of vaccine strains within lymph nodes were monitored. Bison vaccinated with S19 had granulomatous lymphadenitis and greater peak numbers of B. abortus than those vaccinated with SRB51. Bison vaccinated with RB51 had similar histological lesions and B. abortus were still present in lymph nodes at 16 weeks. Although antibodies against RB51 were produced, standard tube agglutination test responses of RB51-vaccinates remained negative. The histological lesions of B. abortus infections in bison were similar to those observed in cattle, but bison did not clear SRB51 as rapidly as cattle.
Olsen
S C
SC
U.S. Department of Agriculture, Brucellosis Research Unit, National Animal Disease Center, Ames, Iowa 50010, USA.
Cheville
N F
NF
Kunkle
R A
RA
Palmer
M V
MV
Jensen
A E
AE
D000372:Agglutination Tests / Q000662:veterinary; D000818:Animals; D000907:Antibodies, Bacterial / Q000096:biosynthesis* / Q000097:blood; D000942:Antigens, Bacterial / Q000032:analysis; D016164:Bison; D002004:Brucella Vaccine / Q000009:adverse effects / Q000276:immunology; D002003:Brucella abortus / Q000276:immunology* / Q000302:isolation & purification*; D002006:Brucellosis / Q000517:prevention & control / Q000662:veterinary; D005260:Female; D015151:Immunoblotting / Q000662:veterinary; D007124:Immunoenzyme Techniques / Q000662:veterinary; D008198:Lymph Nodes / Q000382:microbiology* / Q000473:pathology*; D009333:Neck
D000907:Antibodies, Bacterial; D000942:Antigens, Bacterial; D002004:Brucella Vaccine